These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2093360)

  • 1. [Increase of circulating levels of insulin and C-peptide: common factors in essential hypertension and overweight].
    Sechi LA; Tedde R; Melis A; Pala A; Marigliano A; Orecchioni C; Pisanu G; Bartoli E
    Ann Ital Med Int; 1990; 5(4 Pt 1):348-52. PubMed ID: 2093360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance and beta-cell hypersecretion in essential hypertension.
    Sechi LA; Tedde R; Marigliano A; Melis A; Pala A; Orecchioni C
    J Hypertens Suppl; 1990 Sep; 8(4):S87-9. PubMed ID: 2258791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hyperinsulinemia and ambulatory blood pressure monitoring of lean and overweight male hypertensives.
    Feldstein CA; Renauld A; Akopian M; Olivieri AO; Garrido D
    J Cardiovasc Risk; 1998 Feb; 5(1):25-30. PubMed ID: 9816552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A study on the mechanism of hyperinsulinemia in essential hypertension].
    Guan RJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 1993 Oct; 21(5):266-8, 314. PubMed ID: 8200304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender-specific leptinemia and its relationship with some components of the metabolic syndrome in Moroccans.
    Lyoussi B; Ragala MA; Mguil M; Chraibi A; Israili ZH
    Clin Exp Hypertens; 2005 May; 27(4):377-94. PubMed ID: 15921074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin and C-peptide levels in patients with idiopathic arterial hypertension].
    Kinalska I; Borejszo I; Gosiewska A; Laudański T
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):579-82. PubMed ID: 1488331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and hypertension in postmenopausal women.
    Feldstein CA; Akopian M; Renauld A; Olivieri AO; Cauterucci S; Garrido D
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S145-50. PubMed ID: 11986914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin hypersecretion: a distinctive feature between essential and secondary hypertension.
    Sechi LA; Melis A; Tedde R
    Metabolism; 1992 Nov; 41(11):1261-6. PubMed ID: 1435300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients.
    Colussi G; Catena C; Lapenna R; Nadalini E; Chiuch A; Sechi LA
    Diabetes Care; 2007 Sep; 30(9):2349-54. PubMed ID: 17575088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between blood pressure and serum insulin response in glucose intolerant subjects.
    Ansari AJ; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):55-63. PubMed ID: 8815863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of fasting and post oral glucose serum insulin levels in hypertensive and obese subjects.
    Kothari K; Mathur A; Yadav S
    J Assoc Physicians India; 1998 Jun; 46(6):514-7. PubMed ID: 11273248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOMA-estimated insulin resistance is associated with hypertension in Iranian diabetic and non-diabetic subjects.
    Esteghamati A; Khalilzadeh O; Abbasi M; Nakhjavani M; Novin L; Esteghamati AR
    Clin Exp Hypertens; 2008 Jul; 30(5):297-307. PubMed ID: 18633753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stepwise increase in plasma insulin and C-peptide concentrations in obese, in obese hypertensive, and in obese hypertensive diabetic subjects.
    Donatelli M; Scarpinato A; Bucalo ML; Russo V; Iraci T; Vassallo G
    Diabetes Res; 1991 Jul; 17(3):125-9. PubMed ID: 1841027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians.
    Saad MF; Knowler WC; Pettitt DJ; Nelson RG; Mott DM; Bennett PH
    Diabetes; 1990 Nov; 39(11):1430-5. PubMed ID: 2227116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic risk factors and markers of cardiovascular and renal damage in overweight subjects.
    Bigazzi R; Bianchi S; Batini V; Guzzo D; Campese VM
    Am J Hypertens; 2006 Apr; 19(4):426-31. PubMed ID: 16580581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum insulin, insulin sensitivity, and erythrocyte sodium metabolism in normotensive and essential hypertensive subjects with and without overweight.
    Sechi LA; Melis A; Pala A; Marigliano A; Sechi G; Tedde R
    Clin Exp Hypertens A; 1991; 13(2):261-76. PubMed ID: 2065466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-Hydroxyeicosatetraenoic acid is not associated with circulating insulin in lean to overweight humans.
    Ward NC; Hodgson JM; Puddey IB; Beilin LJ; Croft KD
    Diabetes Res Clin Pract; 2006 Nov; 74(2):197-200. PubMed ID: 16713008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
    Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.